The association between early formula and reduced risk of cow's milk allergy during the first three year of life: a Japanese cohort study.
Child
Cow’s milk
Food allergy
Observational study
Questionnaire survey
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
07 Aug 2022
07 Aug 2022
Historique:
received:
06
06
2022
accepted:
26
07
2022
entrez:
7
8
2022
pubmed:
8
8
2022
medline:
8
8
2022
Statut:
epublish
Résumé
Our recent observational study showed that regular consumption of cow's milk (CM) formula during early infancy (3-6 months old) was associated with a reduced risk of CM allergy (CMA) at 12 months old. However, the long-term association is unclear. The present study was aimed to examine how long this inverse association persists after 12 months old. This study used the dataset of an ongoing nationwide prospective cohort, the Japan Environment and Children's Study, in which participants were registered between January 2011 and March 2014. We analyzed 65,568 children followed-up until 36 months old. The exposure factors were the consumption statuses of formula milk from 0-3, 3-6, and 6-12 months old. The primary outcome was the prevalence of CMA at 6, 12, 18, 24 and 36 months old. CMA was defined as an allergic reaction and sensitization to CM protein in an individual with no or limited intake of this protein at the evaluation time, combined with physician-diagnosed food allergy. Multivariable regression models were used to estimate the association between the periods of formula consumption and the prevalence of CMA. The prevalence of CMA increased with a peak of 1.51% at 18 months old and then declined to 0.79% at 36 months old. Formula milk from 3-6 months old was associated with a reduced risk of CMA throughout the first 3 years of life, although the extent of the reduction was mitigated with age (adjusted relative risk: [95% confidence interval]: 0.19 [0.10-0.34] at 12 months old, 0.23 [0.16-0.33] at 18 months old, 0.41 [0.26-0.64] at 24 months old, and 0.47 [0.26-0.80] at 36 months old). The association between early formula and CMA were observed in both children with and without eczema, but more prominent and long-lasting in the former than the latter. Regular exposure to CM protein during infancy was associated with a reduced prevalence of CMA during early childhood. At present, however, this observational study does not necessarily encourage formula feeding, and randomized controlled trials are warranted to confirm the findings and their significance.
Sections du résumé
BACKGROUND
BACKGROUND
Our recent observational study showed that regular consumption of cow's milk (CM) formula during early infancy (3-6 months old) was associated with a reduced risk of CM allergy (CMA) at 12 months old. However, the long-term association is unclear. The present study was aimed to examine how long this inverse association persists after 12 months old.
METHODS
METHODS
This study used the dataset of an ongoing nationwide prospective cohort, the Japan Environment and Children's Study, in which participants were registered between January 2011 and March 2014. We analyzed 65,568 children followed-up until 36 months old. The exposure factors were the consumption statuses of formula milk from 0-3, 3-6, and 6-12 months old. The primary outcome was the prevalence of CMA at 6, 12, 18, 24 and 36 months old. CMA was defined as an allergic reaction and sensitization to CM protein in an individual with no or limited intake of this protein at the evaluation time, combined with physician-diagnosed food allergy. Multivariable regression models were used to estimate the association between the periods of formula consumption and the prevalence of CMA.
RESULTS
RESULTS
The prevalence of CMA increased with a peak of 1.51% at 18 months old and then declined to 0.79% at 36 months old. Formula milk from 3-6 months old was associated with a reduced risk of CMA throughout the first 3 years of life, although the extent of the reduction was mitigated with age (adjusted relative risk: [95% confidence interval]: 0.19 [0.10-0.34] at 12 months old, 0.23 [0.16-0.33] at 18 months old, 0.41 [0.26-0.64] at 24 months old, and 0.47 [0.26-0.80] at 36 months old). The association between early formula and CMA were observed in both children with and without eczema, but more prominent and long-lasting in the former than the latter.
CONCLUSIONS
CONCLUSIONS
Regular exposure to CM protein during infancy was associated with a reduced prevalence of CMA during early childhood. At present, however, this observational study does not necessarily encourage formula feeding, and randomized controlled trials are warranted to confirm the findings and their significance.
Identifiants
pubmed: 35934704
doi: 10.1186/s13223-022-00712-z
pii: 10.1186/s13223-022-00712-z
pmc: PMC9358901
doi:
Types de publication
Journal Article
Langues
eng
Pagination
71Investigateurs
Michihiro Kamijima
(M)
Shin Yamazaki
(S)
Yukihiro Ohya
(Y)
Reiko Kishi
(R)
Nobuo Yaegashi
(N)
Koichi Hashimoto
(K)
Chisato Mori
(C)
Shuichi Ito
(S)
Zentaro Yamagata
(Z)
Hidekuni Inadera
(H)
Takeo Nakayama
(T)
Hiroyasu Iso
(H)
Masayuki Shima
(M)
Youichi Kurozawa
(Y)
Narufumi Suganuma
(N)
Koichi Kusuhara
(K)
Takahiko Katoh
(T)
Informations de copyright
© 2022. The Author(s).
Références
J Allergy Clin Immunol. 2010 Jul;126(1):77-82.e1
pubmed: 20541249
World Allergy Organ J. 2020 Nov 07;13(11):100479
pubmed: 33204389
Pediatr Allergy Immunol. 2008 Aug;19(5):375-80
pubmed: 18266825
Clin Exp Allergy. 2021 Jan;51(1):99-107
pubmed: 33053241
J Allergy Clin Immunol. 2016 Apr;137(4):998-1010
pubmed: 27059727
J Allergy Clin Immunol. 2021 Jan;147(1):224-232.e8
pubmed: 32890574
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
J Epidemiol. 2018 Feb 5;28(2):99-104
pubmed: 29093304
J Dermatol Sci. 2016 Nov;84(2):144-148
pubmed: 27523805
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):481-488.e2
pubmed: 27157937
J Allergy Clin Immunol. 2012 May;129(5):1187-97
pubmed: 22464642
N Engl J Med. 2016 May 5;374(18):1733-43
pubmed: 26943128
Lancet. 2017 Jan 21;389(10066):276-286
pubmed: 27939035
BMC Public Health. 2014 Jan 10;14:25
pubmed: 24410977
Clin Exp Allergy. 2000 Mar;30(3):400-6
pubmed: 10691899
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001
J Allergy Clin Immunol Pract. 2019 Feb;7(2):462-470.e1
pubmed: 30267891